- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 126
Ventus tears into $60m series A
GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.
May 7, 2020Ventus tears into $60m series A
GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.
May 7, 2020Alpian scales $12.5m series A
Financial services provider Reyl and Cie has spun out Alpian in a bid to claim what it views as the market opportunity for a digital Swiss banking firm.
May 7, 2020Helium Health takes off with $10m series A
Tencent was among the investors in a $10m series A round for the digital health platform that was co-led by Global Ventures and Africa Healthcare Masterfund.
May 7, 2020Tehama tees up $10m series A
Workforce collaboration software business Tehama, a spinout of IT services firm Pythian, attracted investors including Omers Ventures for its first funding round.
May 6, 2020ZAF Energy stores $22m
ZAF Energy Systems has raised $45.6m to date after a series A round that featured the corporate venture capital arm of Holt Cat.
May 5, 2020Daily deal net: May 4, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 4, 2020Hypersonix accelerates with series A
Intel Capital led an $11.5m series A round for Hypersonix, the creator of an artificial intelligence-driven autonomous analytics platform for consumer commerce data.
May 4, 2020Corporate venturing deal net: 27 April-1 May 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
May 1, 2020Genespire generates $17.6m
San Raffaele-Telethon gene therapy spinout Genespire has picked up series A funding from Sofinnova Partners to target inherited metabolic diseases and primary immunodeficiencies.
May 1, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


